| Literature DB >> 15622821 |
Jennifer Perfetti1, Roseanne Clark, Capri-Mara Fillmore.
Abstract
Depression during the postpartum period is a significant public health concern, affecting 8%-15% of women and resulting in considerable morbidity for women, and their infants and families. Risk, prevalence, and distinguishing features of postpartum mood disorders are provided. Anxiety and depression frequently co-occur, suggesting symptoms of anxiety should also be attended to when screening for postpartum depression. Recommendations include the use of a brief, valid screening instrument as a routine clinical practice and the unique role of the obstetrician/gynecologist, pediatrician, and family practice physician in identification and referral. A summary of evidence-based treatment options for postpartum depression, along with current information about psychotropic medication, is provided to assist in risk-benefit analyses and decision making with patients.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15622821
Source DB: PubMed Journal: WMJ ISSN: 1098-1861